Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139

NCT02362464 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

NIH

Sponsor class

Conditions

Prostatic Neoplasms
Neoplasms of Prostate
Prostate Cancer
Cancer Of Prostate
Stage D0 Prostate Cancer

Interventions

BIOLOGICAL: Multi-epitope (ME) T-cell Receptor Alternate Reading Frame Protein (TARP) vaccine

Sponsor

National Cancer Institute (NCI)